Shannon T. Kelley, General Counsel at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 692 shares at $501.40 ($344K) on 2026-01-20, disclosed to the SEC on 2026-01-20.
Scheduled sale ($344k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $490.77 | 263 | $129K | 37.5% |
| 2 | $501.40 | 429 | $215K | 62.5% |
| Total | $497.36 avg | 692 | $344K | 100% |
| Filing → |
| MDGL | SELL | 2025-08-18 | $809K | — | Filing → |
| MDGL | SELL | 2025-03-05 | $139K | — | Filing → |
| MDGL | SELL | 2025-01-17 | $151K | — | Filing → |